Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation

Härtel C, Herting E, Humberg A, Hanke K, Mehler K, Keller T, Mauer I, Frieauff E, Meyer S, Thome UH, Wieg C, Schmidtke S, Kribs A, Göpel W, Faust K, Müller D, Gebauer C, Guthmann F, von der Wense A, Stangl O, Weller U, Höhn T, Olbertz D, Felderhoff-Müser U, Rossi R, Teig N, Heitmann F, Heckmann M, Laux R, Bohnhorst B, Roth B, Vochem M, Keller-Wackerbauer A, Möller J, Eichhorn J, Wintgens J, Böttger R, Reese J, Hubert M, Dördelmann M, Hillebrand G, Roll C, Jensen R, Rüdiger M, Werner C, Longardt AC, Schäfer S, Schaible T, Franz A, Heldmann M, Kunzmann S, Schmidt E, Orlikowsky T, Gerleve H, Depping N, Haase R, Hoppenz M, Seeliger S, Küster H, Fuchs H, Körner T, Brune T, Müller A, Urlichs F, Berghäuser M, Proquitté H, Morhart P, Lindner W, Schlösser R, Schneider W, Schroth M, Rieger-Fackeldey E, Dohle F, Sinnecker G, Völkl T, Nunez FB, Welsch M, Krüger M (2022)


Publication Type: Journal article

Publication year: 2022

Journal

Book Volume: 5

Article Number: e2225810

Journal Issue: 8

DOI: 10.1001/jamanetworkopen.2022.25810

Abstract

Importance: The inclusion of less invasive surfactant administration (LISA) in the care of preterm infants has been found to be beneficial for respiratory outcomes. Recently, the OPTIMIST trial found higher mortality rates in the subgroup of infants born at 25 to 26 weeks' gestational age (GA) who received surfactant treatment while spontaneously breathing. Objective: To analyze outcomes among LISA-exposed, highly vulnerable babies born at less than 27 weeks' GA within the large-scale observational cohort of the German Neonatal Network. Design, Setting, and Participants: In this cohort study of data from 68 tertiary level neonatal intensive care units in Germany of infants born between 22 weeks 0 days to 26 weeks 6 days of gestation between April 1, 2009, and December 31, 2020, short-term outcomes among infants receiving LISA vs infants not receiving LISA were compared. Exposure: Use of LISA within the first 72 hours of life. Main Outcomes and Measures: The main outcomes were rates of LISA use, use of mechanical ventilation within the first 72 hours (considered failure of LISA), and association of LISA with outcomes, including death from all causes, bronchopulmonary dysplasia (BPD), death and BPD combined, pneumothorax, retinopathy of prematurity, intracerebral hemorrhage, and periventricular leukomalacia. To address potential confounding factors, multivariate logistic regression models were used. Results: A total of 6542 infants (3030 [46.3%] female and 3512 [53.7%] male; mean [SD] GA, 25.3 (1.1) weeks; mean [SD] birth weight, 715 [180] g) were analyzed; 2534 infants (38.7%) received LISA, which was most frequently given quasi-prophylactically during delivery room management. Among the infants who received LISA, 1357 (53.6%) did not require mechanical ventilation in the first 72 hours compared with 331 infants (8.3%) of 4008 who did not receive LISA. In a multivariate logistic regression model that adjusted for GA, small-for-GA status, sex, multiple birth, inborn status, antenatal steroid use, and maximum fraction of inspired oxygen in the first 12 hours of life, LISA was associated with reduced risks of all-cause death (odds ratio [OR], 0.74; 95% CI, 0.61-0.90; P =.002), BPD (OR, 0.69; 95% CI, 0.62-0.78; P <.001), and BPD or death (OR, 0.64; 95% CI, 0.57-0.72; P <.001) compared with infants without LISA exposure. Conclusions and Relevance: The results of this long-term multicenter cohort study suggest that LISA may be associated with reduced risks of adverse outcomes in extremely preterm infants.

Involved external institutions

Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Georg-August-Universität Göttingen DE Germany (DE) Universität zu Köln DE Germany (DE) Universitätsklinikum Leipzig DE Germany (DE) Städtische Kliniken Mönchengladbach GmbH / Elisabeth-Krankenhaus Rheydt DE Germany (DE) Universitätsklinikum Köln DE Germany (DE) Altonaer Kinderkrankenhaus (AKK) DE Germany (DE) GFO Kliniken Bonn DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Universitätsklinikum Freiburg DE Germany (DE) Vivantes - Netzwerk für Gesundheit GmbH DE Germany (DE) Klinikum Nürnberg DE Germany (DE) Kinder- und Jugendkrankenhaus Auf der Bult DE Germany (DE) Asklepios Klinik Barmbek DE Germany (DE) HELIOS Kliniken DE Germany (DE) Universitätsklinikum Tübingen DE Germany (DE) Barmherzige Brüder Klinik St. Hedwig Regensburg DE Germany (DE) Sana Kliniken Ostholstein DE Germany (DE) Gemeinschaftsklinikum Mittelrhein DE Germany (DE) Klinikum Aschaffenburg-Alzenau DE Germany (DE) Evangelisches Klinikum Bethel DE Germany (DE) Westküstenkliniken Brunsbüttel und Heide gGmbH DE Germany (DE) Universitätsklinikum Bonn DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Universitätsklinikum Jena DE Germany (DE) München Klinik gGmbH DE Germany (DE) Josefinum Augsburg DE Germany (DE) Florence Nightingale Hospital / Florence-Nightingale-Krankenhaus DE Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School DE Germany (DE) Klinikum Dortmund DE Germany (DE) Kliniken der Stadt Köln DE Germany (DE) Universitätsklinikum Aachen (UKA) DE Germany (DE) Universität Greifswald DE Germany (DE) Universitätsklinikum des Saarlandes (UKS) DE Germany (DE) Universitätsklinikum Essen DE Germany (DE) Bürger­hospital Frankfurt DE Germany (DE) Julius-Maximilians-Universität Würzburg DE Germany (DE) Klinikum rechts der Isar DE Germany (DE) St. Vincenz-Kliniken GmbH DE Germany (DE) Universität Witten/Herdecke DE Germany (DE) Klinikum Links der Weser DE Germany (DE) Katholisches Klinikum Bochum (St. Josef- und St. Elisabeth-Hospital gGmbH) DE Germany (DE) Klinikum Kassel GmbH DE Germany (DE) Klinikum Stuttgart DE Germany (DE) Klinikum Itzehoe DE Germany (DE) Universitätsklinikum Magdeburg A.ö.R. DE Germany (DE) Westfälische Wilhelms-Universität (WWU) Münster DE Germany (DE) Klinikum Lippe DE Germany (DE) Sana Kliniken AG DE Germany (DE) Klinikum Südstadt Rostock DE Germany (DE) DRK-Kinderklinik Siegen DE Germany (DE) Diakonissenkrankenhaus Flensburg DE Germany (DE) Cnopf'sche Kinderklinik DE Germany (DE) Universitätsklinikum Halle (Saale) DE Germany (DE) Heinrich-Heine-Universität Düsseldorf DE Germany (DE) Klinikum Wolfsburg DE Germany (DE) Klinikum Leverkusen DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) St. Franziskus-Hospital Münster DE Germany (DE) Asklepios Kliniken DE Germany (DE) DONAUISAR Klinikum Deggendorf-Dingolfing-Landau DE Germany (DE)

How to cite

APA:

Härtel, C., Herting, E., Humberg, A., Hanke, K., Mehler, K., Keller, T.,... Krüger, M. (2022). Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation. JAMA Network Open, 5(8). https://doi.org/10.1001/jamanetworkopen.2022.25810

MLA:

Härtel, Christoph, et al. "Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation." JAMA Network Open 5.8 (2022).

BibTeX: Download